CompletedPhase 3Phase 4ACTRN12605000611628
DOES USE OF INHALED FLUTICASONE PRIOR TO AN ADENOSINE 5'MONOPHOSPHATE (AMP) BRONCHIAL PROVOCATION TEST AFFECT THE PERCEPTION OF DYSPNOEA?
DOES USE OF INHALED FLUTICASONE PRIOR TO AN ADENOSINE 5'MONOPHOSPHATE (AMP) BRONCHIAL PROVOCATION TEST AFFECT THE PERCEPTION OF DYSPNOEA in asthmatic patients and the development of nasal symptoms?
Sponsor
Woolcock Institute of Medical Research
Enrollment
12 participants
Start Date
Oct 1, 2005
Study Type
Interventional
Conditions
Eligibility
Sex: Both males and females
Inclusion Criteria1
- Allergy to inhaled allergens. Mild asthma and rhinitis.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Fluticasone 250mcg inhaled 2 or 14 hours before Adenosine 5' Monophostate Bronchial provocation. Perception of Dyspnoea and Nasal symptoms developed are recorded.
Fluticasone 250mcg inhaled 2 or 14 hours before Adenosine 5' Monophostate Bronchial provocation. Perception of Dyspnoea and Nasal symptoms developed are recorded.
Locations(1)
View Full Details on ANZCTR
For the most up-to-date information, visit the official listing.
ACTRN12605000611628
Related Trials
A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Combination in Participants 12 Years and Older With Asthma
NCT06664619178 locations
Execise Intervention in Adult Severe Asthma
NCT076550371 location
TQC2731 Clinical Trial for the Treatment of Severe Asthma With Injection
NCT06829784101 locations
Personalized Environment and Genes Study
NCT003412372 locations
Role of Genetic Factors in the Development of Lung Disease
NCT000015322 locations